incretin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-25 and is reviewed periodically as new material appears.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Stability studies focus on deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation into higher-order species. The fatty acid side chain adds susceptibility to oxidative change and can promote self-association at high concentration. Lyophilised material is comparatively robust when kept cold and dry, while aqueous solutions require refrigeration and protection from light. Forced degradation experiments under heat, acid, base, and peroxide conditions establish the specificity of each analytical method. Which degradation route dominates under real storage conditions depends on the formulation and stays formulation-specific.
Handling guidance for research quantities calls for single-use aliquots, an inert atmosphere where practical, and avoidance of repeated freeze-thaw cycles that accelerate aggregation. Certificates of analysis typically report purity by peak area, water content, counter-ion identity, and residual solvent levels. In the scientific literature the compound is usually described by its full amino acid sequence, its registry number, or its structural class rather than by any proprietary label. Reporting standards vary between journals, and reviewers increasingly request raw chromatograms alongside tabulated purity figures. Whether current purity thresholds are adequate for every experimental context is debated.
| Property | Value | Notes |
|---|---|---|
| Chemical class | GLP-1 receptor agonist peptide | Mimics endogenous incretin signaling |
| Molecular mass | Approximately 4114 Da | Modified 31-amino-acid backbone |
| Appearance | White to off-white powder | Typical of lyophilized peptide material |
| Solubility | Soluble in water | Behavior depends on salt form and buffer |
| Elimination half-life | About one week | Supported by albumin binding and protease resistance |
Lyophilised material appears as a white to off-white cake or powder that is hygroscopic, and containers are usually equilibrated to room temperature before opening to limit condensation. Dissolution is performed in water, phosphate-buffered saline, or a mildly alkaline buffer, since solubility rises above neutral pH. Gentle inversion or low-speed mixing is preferred, because vigorous vortexing can promote surface denaturation and aggregation. Complete dissolution may require several minutes, and brief sonication is sometimes applied. Passing the solution through a 0.22 micrometre membrane removes particulates but does not by itself sterilise the liquid.
Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
== Herstellung und Gewinnung == Das Vorprodukt Phenylacetylcarbinol entsteht bei der mikrobiellen Acylierung von Benzaldehyd. Die weiteren Schritte sind Kondensation des Phenylacetylcarbinols mit Methylamin und die anschließende katalytische Reduktion zu Ephedrin. Auf diesem Weg entsteht fast nur die optisch aktive L-(−)-Form des Ephedrins. Der Wirkstoff kann jedoch auch aus verschiedenen Ephedra-Arten gewonnen werden wie zum Beispiel Ephedra distachya oder Ephedra sinica. Eine Gewinnung kann ähnlich wie bei Coffein durch Extraktion aus Pflanzenteilen erfolgen.
== Analytik == Zur zuverlässigen qualitativen und quantitativen Bestimmung von Ephedrin wird die Kopplung von Gaschromatographie und HPLC mit der Massenspektrometrie nach angemessener Probenvorbereitung eingesetzt. Für gaschromatographische Nachweise werden häufig Derivatisierungen vorgenommen. Die Bestimmung vermittels der HPLC kann in der Regel auch ohne Derivatisierung durchgeführt werden. Diese Analytik eignet sich ebenfalls zur Bestimmung von Ephedrin in Nahrungsmittelsupplementen. Auch die zuverlässige Bestimmung in Abwasserproben ist mit den genannten Verfahren möglich.
Stonehenge [stəʊ̯n'hɛndʒ] ist ein Megalith-Bauwerk der Jungsteinzeit nahe des Flusses Avon bei Amesbury in Wiltshire, Südwestengland. Es wurde ab wenigstens 3000 v. Chr. in mehreren nach und nach aufeinander folgenden Versionen errichtet. Die Anlage wurde mindestens bis in die Bronzezeit weiter genutzt und danach aufgegeben, wohl vor 1400 v. Chr. Seither wurde sie stark beschädigt. Die wohl anspruchsvollste Bauphase, Stonehenge 3, mit ihren an Kolonnaden gemahnenden monumentalen Steinkreisen mit Aufliegern fand etwa zeitgleich mit der Errichtung der Cheopspyramide in Ägypten statt, und der in Stonehenge verwendete Blaustein ist als Basalt etwa so hart wie der in Ägypten verwendete Granit. Umfangreiche Bautätigkeiten über mehrere Jahrhunderte und nicht zuletzt der Transport der bluestones, vom Ort ihrer Gewinnung im heutigen Wales über 250 Kilometer zur Baustelle deuten auf großräumige organisatorische Strukturen in den Haupt-Bauzeiten, über die nichts Näheres bekannt ist. Ein entscheidender Aspekt bei der Einordnung von Stonehenge in die Geschichte der Britischen Inseln liegt in deren Siedlungsgeschichte: Bald nach der Fertigstellung von Stonehenge 3 III begann die indoeuropäische Invasion der Inseln, in deren Verlauf die Träger der „Stonehenge-Kultur“ zu einer Randgruppe von nur noch 10 % der Bevölkerung wurden. Auch die Kelten waren schon ein Teil dieser Invasion. Ab 1918 ging das Monument in den Besitz des Staates über; verwaltet und touristisch erschlossen wird es vom English Heritage, seine Umgebung vom National Trust.
== Spekulationen und Konsens == Über den Anlass und letztlichen Zweck dieses aufwendig konzipierten Monuments existieren verschiedene, sich teils ergänzende, auch sich widersprechende Hypothesen. Sie reichen von der Annahme einer Stätte für Begräbnisse und andere religiöse Kulte bis zu der eines astronomischen Observatoriums mit Kalenderfunktionen (u. a. für die Saatzeiten). Alle Hypothesen, auch die eher rein spekulativen, stimmen in einem Punkt überein: Die Hufeisen und die ihren Öffnungen senkrecht vorangestellten Steine sind exakt auf den damaligen Sonnenaufgang am Tag der Sommersonnenwende ausgerichtet. Wegen der gebrochenen Symmetrie in diesen – von oben betrachtet – Hufeisen-ähnlichen Bögen unterscheidet sich Stonehenge deutlich von jenen Monumenten, die lediglich aus Steinkreisen bestehen.
Sources: de.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.
Yes. Stimulation of insulin secretion is glucose-dependent, meaning the effect is larger when blood glucose is high and minimal when it is normal. This property separates GLP-1 receptor agonists from agents that drive insulin release regardless of glucose level.
Receptor expression in hypothalamic and brainstem regions is well documented, and reduced energy intake is consistently observed. The relative contribution of central versus peripheral signaling to total weight change is still an open question addressed by ongoing research.
Purity is commonly expressed as the percentage of the main peak relative to all integrated peaks in a reversed-phase chromatogram. Related substances and counter-ions are reported separately. Values obtained with different detectors are not always directly comparable.